Device follow-up for certain MicroPort CRM heart implants
Part of Heart & circulation clinical trials.
This study checks how well specific MicroPort CRM heart devices and leads work in real life over time. If you already have one of these FDA/market-approved implants and can be followed yearly, the study helps the company monitor safety and performance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 90 years old, and able to consent (or legally allowed to be in the study)
- You have a specific MicroPort CRM heart device implanted since January 1, 2020 (or a future approved related MicroPort device)
- Your implanted device also includes the required MicroPort leads (pacing leads and/or a defibrillator lead, depending on your system)
- If you have an ICD or CRT-D device, you must have remote monitoring set up
- You can do follow-up yearly with a clinic visit or remote check, as your site requires
- You must sign the informed consent form if your country requires it
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows how well certain Medtronic heart devices work over the long term. You may be included if you have a qualifying Medtronic implant and the research team can reliably get your implant and follow-up information.
This study is testing a new type of implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) called the CorSky Family. The goal is to see how well it works for people who need a device to help their heart pump properly and prevent dangerous rhythms.
This trial is a registry that collects real-world information from people who receive an S-ICD (a small device under the skin) to help doctors learn how these devices perform over time. You may qualify if you already had the implant and can be followed for at least one month.
This trial tests whether using an MRI to guide the placement of a defibrillator (ICD) helps people with weak hearts. It might offer a more precise way to implant the device.
This study looks at whether implantable defibrillators can reduce dangerous heart rhythms in people with non-ischemic cardiomyopathy (heart weakness not caused by blocked heart arteries), a heart scar, and very low pumping strength despite best treatment. It compares different approaches to choosing which patients should receive these devices.
This study tests a heart failure alert system called HeartInsight in people who recently received an ICD or CRT-D device. The goal is to see if the alerts help doctors manage care better. You may qualify if you got a new (not replacement) device less than a year ago.
Hear when a new Cardiac Rhythm Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.